Demand for Health & Safety Products at a Fever Pitch
With the number of coronavirus cases around the world continuing to climb, demand for preventive products has skyrocketed. Critical items such as hand sanitizers, masks and gloves are flying off the shelves as people continue to stock up amid the worsening scenario.
Medical, health and safety products are currently in short supply amid the pandemic that has so far claimed more than 42,000 lives and infected more than 850,000 people globally. Notably, outbreak in the United States, Italy, Spain, Germany and France has worsened over the past several days. It has rattled global stock markets on concerns over broader economic impacts.
Dr. Maria Van Kerkhove, an infectious disease epidemiologist with the World Health Organization (WHO), recently said that the world is facing a significant shortage of PPE including masks, respirators, gloves, gowns and face shields for frontline health workers.
The WHO, last month, had called on manufacturers to increase production of PPE by 40% to meet the rising global demand. The WHO is concerned that limited access to PPE supplies has left frontline workers “dangerously ill-equipped” to care for COVID-19 patients. It has urged governments to provide incentives to the industry for ramping up production of PPE and other medical supplies.
While demand for PPE first spiked in China, where the outbreak originated, it rapidly surged across the world to an unprecedented level with the spread of the lethal virus.
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pfizer's paxlovid reduces the risk of COVID-19 by 26%
-
The battle between Pfizer and Gilead over COVID-19 drugs will continue
-
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease
-
Twenty-five COVID-19 Vaccines In China Enter Stages Of Clinical Trials
-
Pfizer to Increase Production Capacity of COVID-19 Oral Drugs, Invest 120 Million US Dollars
-
Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant Strains Such as COVID-19 Omicron
-
As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid Generic Drug Price Released
-
Survey On Corona Deaths By Country
-
COVID-19 Drug Remdesivir Approved for Infants And Young Children
-
Roche's Q1 Performance Increases by 10%, And Total Revenue for the Year May Slow Down Due to COVID-19, Biosimilar Competition
Recommend Reading
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
Brazil Expands Chemical Tax Breaks as India’s Crop Protection Industry Warns of a 25% Cost Increase
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
FDA Slams Door on Chinese Food Exports: Inspection Refusals Trigger Automatic Detentions
-
Recent Butadiene Rubber Market First Rapidly Surged, Then Experienced High-level Fluctuations
-
Premium Global Chemical Sourcing Requests (17-20Sep.,2026)
-
Business Society’s Market Outlook for Fuel Oil 180CST on August 17, 2026: Volatile (Bullish Tendency)
-
Business Society’s MTBE Market Outlook on August 17, 2026: Slightly Bearish Consolidation
-
This Week, the Transaction Focus of China's Propylene Oxide Market Rises (11.10-11.14)
- Hot Searches
- retatrutida price
- elite-chems
- phenylpiracetam hydrazide buy
- phenolic resin powder
- stanozolol sale
- na 931 buy online
- cerebrolysin for sale
- best research chemical website
- drostanolone enanthate powder
- tci 4-chlorobenzaldehyde 25 g price
- sodium potassium mag sulfates 17.5 gram-3.13 gram-1.6 gram oral solution
- hobt sds